Cow's milk protein allergy is one of the most common diagnoses in the first year of life, and it is also one of the most commonly missed or delayed — partly because its symptoms overlap so significantly with other common infant conditions, and partly because the non-IgE-mediated (delayed) form does not produce the dramatic immediate reactions that parents and clinicians associate with allergy.
Understanding the spectrum of presentations, the appropriate diagnostic approach, and the management options empowers parents to advocate effectively for assessment if they are concerned, and to manage the diagnosis confidently once it is made.
Healthbooq supports parents navigating infant feeding challenges including allergy management, with evidence-based guidance on diet modifications and formula options.
Types of Cow's Milk Protein Allergy
CMPA exists on a spectrum determined by the immune mechanism involved. IgE-mediated CMPA produces rapid reactions — typically within minutes to two hours of exposure — and may include hives, swelling around the mouth, vomiting, and in severe cases anaphylaxis. These are the reactions most commonly recognised as allergy.
Non-IgE-mediated CMPA produces delayed reactions — typically two to seventy-two hours after exposure — and its symptoms are subtler and more likely to be attributed to other causes. Symptoms include persistent reflux or vomiting, blood or mucus in stool, constipation or diarrhoea, significant colic-like distress, poor weight gain, and eczema that is difficult to control. Because these symptoms overlap so extensively with physiological reflux, colic, and other common conditions, non-IgE-mediated CMPA is frequently underdiagnosed.
Mixed CMPA has features of both IgE and non-IgE reactions.
Diagnosis
For IgE-mediated CMPA, skin prick testing and specific IgE blood tests (sometimes called RAST tests) can confirm sensitisation. For non-IgE-mediated CMPA, there is no reliable blood test — diagnosis is made clinically, based on the pattern of symptoms and the response to an elimination trial.
An elimination trial — removing all cow's milk protein from the infant's diet (and from the breastfeeding mother's diet if the baby is breastfed) for two to four weeks and observing whether symptoms improve — is the primary diagnostic tool for non-IgE-mediated CMPA. This should be done with medical guidance.
Management
For formula-fed infants with CMPA, cow's milk-based formula must be replaced with a hypoallergenic alternative. Extensively hydrolysed formula (eHF) — in which the milk proteins are broken down into small fragments — is the first-line alternative and is tolerated by most babies with CMPA. Amino acid-based formula (AAF) — in which synthetic individual amino acids replace intact or fragmented proteins entirely — is used for babies who do not tolerate eHF or who have severe CMPA. Soya formula is not recommended as first-line management because approximately fifty percent of babies with CMPA also react to soya.
Goat's milk formula is not appropriate for babies with CMPA because the proteins are structurally similar to cow's milk proteins and cross-reaction is very common.
Breastfed babies with CMPA require the mother to follow a dairy-free diet. Maternal calcium intake must be maintained via dairy-free sources (fortified plant milks, green vegetables, fortified foods) or supplements when dairy is eliminated.
Outgrowing CMPA
Most babies with CMPA outgrow the allergy — around fifty percent by age one, seventy-five percent by two, and ninety percent by three years. Reintroduction of dairy is typically guided by a structured "milk ladder" approach that gradually increases the amount and form of milk protein introduced, starting with baked milk products (which are tolerated earlier because heat changes the protein structure) and progressing toward fresh milk. This should be guided by a GP and dietitian.
Key Takeaways
Cow's milk protein allergy (CMPA) is the most common food allergy in infants, affecting two to three percent of babies. It causes a range of symptoms that overlap with other common infant conditions — reflux, colic, eczema, constipation, and diarrhoea — which often means diagnosis is delayed. CMPA can be IgE-mediated (immediate reactions within minutes to two hours) or non-IgE-mediated (delayed reactions occurring hours to days after exposure). Management involves elimination of cow's milk protein from the infant's diet (and the breastfeeding mother's diet if breastfed) and substitution with an appropriate hypoallergenic formula if formula-fed.
